American Academy of Neurology Position Statement on Physician Reporting of Medical Conditions That May Affect Driving Competence
Neurol 68: 1174-1177,1170, Bacon,D.,et al, 2007
Factors Associated With Poor Compliance of Patients with Epilepsy Driving Restrictions
Neurol 67:869-871, Polychronopoulos,P.,et al, 2006
Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Stroke 48:1416-1419, Labovitz, D.L.,et al, 2017
Is Prophylactic Anticoagulation for Deep Venous Thrombosis Common Practice after Intracerebral Hemorrhage?
Stroke 46:369-375, Prabhakaran, S.,et al, 2015
When it is Safe to Return to Driving Following First-Ever Seizure?
JNNP 86:60-64, Brown, J.W.L.,et al, 2015
Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015
Doctors and Dangers of Driving
NEJM 370:8-11, Jones, D.S., 2014
Dietary Treatment in Adults with Refractory Epilepsy
Neurol 83:1978-1985, Klein, P.,et al, 2014
Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke
Stroke 44:528-530, Kamel, H.,et al, 2013
Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012
Preexposure Prophylaxis for HIV - Where Do We Go from Here?
NEJM 367:459-461,462, Cohen, M.S. & Baden, L.R., 2012
Screening for Fitness to Drive After Stroke: A Systematic Review and Meta-Analysis
Neurol 76:747-756, e35, Devos,H.,et al, 2011
Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011
Failure to Take Antiepileptic Drugs as Prescribed
Arch Neurol 68:1318-1320, Modur, P.N., 2011
The Older Adult Driver with Cognitive Impairment: "Its a Very Frustrating Life"
JAMA 303:1632-1641, 1642, 1660, Carr,D.B. &Ott,B.R., 2010
Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes: A Systematic Review
Arch Neurol 67:931-940, Neligan,A., et al, 2010
Risk of Recurrence After a First Seizure and Implications for Driving: Further Analysis of the Multicentre Study of Early Epilepsy and Single Seizures
BMJ 341:c6477, 1227, Bonnet,L.J.,et al, 2010
The Safety of Driving a Commercial Motor Vehicle After a Stroke
Stroke 41:2991-2996, Rabadi,M.H.,et al, 2010
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009
Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
Stroke 40:213-220, Kettani,F.-Z.,et al, 2009
Nonadherence to Antiepileptic Drugs and Increased Mortality: Findings from the RANsom Study
Neurol 71:1572-1578, Faught,E.,et al, 2008
Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians
Stroke 39:227-230,7, Gattellari,M.,et al, 2008
A longitudinal Study of Drivers With Alzheimer Disease
Neurol 70:1171-1178, Ott, B.R.,et al, 2008
Predictors of Fitness to Drive in People With Parkinson Disease
Neurol 69:1434-1441, Devos,H.,et al, 2007
Epilepsy in Pregnancy
BMJ 335:769-774, Tomson,T. &Hiilesmaa,V., 2007
Lamotrigine Extended-Release as Adjunctive Therapy for Partial Seizures
Neurol 69:1610-1618, Naritoku,D.K.,et al, 2007
Parkinsons Disease and Driving Ability
JNNP 78:363-366, Singh,R.,et al, 2007
Impaired Visual Search in Drivers with Parkinsons Disease
Ann Neurol 60:407-413,387, Uc,E.Y.,et al, 2006
The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006
Unusual Variants of Alexander's Disease
Ann Neurol 57:327-338, van der Knaap,M.S., et al, 2005
Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients
BMJ 326:21, Maas,R.,et al, 2003
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Diagnosis of McArdle's Disease by Molecular Genetic Analysis of Blood
Neurol 47:579-580, El-Schahawi,M.,et al, 1996
Double-Blind Crossover of Tegretol-XR and Tegretol in Patients with Epilepsy
Tegretol OROS Study Grp, Neurol 45:1703-17071995., , 1995
Optimizing Long-Term Patient Compliance
Neurol 45(Suppl 1):S25-S28, Cramer,J.A., 1995
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Rapid Direct Diagnosis of Deletions Carriers of Duchenne and Becker Muscular Dystrophies
Lancet 344:302-303, Fassati,A.,et al, 1994
Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994
Persistence of Initial Infection in Recurrent Cryptococcus Neuformans Meningitis
Lancet 341:595-596, Spitzer,E.D.,et al, 1993
Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993
Molecular Genetic Heterogeneity of Myophosphorylase Deficiency (McArdle's Disease)
NEJM 329:241-245, Tsujino,S.,et al, 1993
Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992
Central Nervous System Lesions in von Hippel-Lindau Syndrome
JNNP 55:898-901, Neumann,H.P.H.,et al, 1992